GLUCOSE HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.351 USD | +6.04% |
|
-12.25% | +25.36% |
| 04-01 | Glucose Health, Inc. Announces Expansion of Fiber Up®? Brand - More Drink Mix Flavors and New Fiber Up®? Gumdrops | CI |
| 2023 | Glucose Health, Inc. Announces Availability of FIBER Up | CI |
Valuation
| Fiscal Period: December | 2016 | 2020 | 2021 |
|---|---|---|---|
| Capitalization 1 | 0.1365 | 68.6 | 22.85 |
| Enterprise Value (EV) 1 | 0.4678 | 68.65 | 22.1 |
| P/E ratio | -0.28 x | -142 x | -62.7 x |
| Yield | - | - | - |
| Capitalization / Revenue | 0.44 x | 143 x | 24 x |
| EV / Revenue | 1.49 x | 143 x | 23.2 x |
| EV / EBITDA | -5.4 x | -110 x | -65.8 x |
| EV / FCF | 6.89 x | - | -453 x |
| FCF Yield | 14.5% | - | -0.22% |
| Price to Book | -0.22 x | 338 x | 20 x |
| Nbr of stocks (in thousands) | 3,312 | 11,628 | 13,849 |
| Reference price 2 | 0.0412 | 5.900 | 1.650 |
| Announcement Date | 29/03/17 | 01/06/22 | 01/06/22 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2016 | 2020 | 2021 |
|---|---|---|---|
| Net sales 1 | 0.3132 | 0.4807 | 0.9537 |
| EBITDA 1 | -0.0866 | -0.6243 | -0.3361 |
| EBIT 1 | -0.0866 | -0.6244 | -0.3361 |
| Operating Margin | -27.66% | -129.88% | -35.24% |
| Earnings before Tax (EBT) 1 | -0.4104 | -0.4777 | -0.3389 |
| Net income 1 | -0.4104 | -0.4777 | -0.3389 |
| Net margin | -131.04% | -99.37% | -35.54% |
| EPS 2 | -0.1469 | -0.0417 | -0.0263 |
| Free Cash Flow 1 | 0.0679 | - | -0.0488 |
| FCF margin | 21.67% | - | -5.11% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 29/03/17 | 01/06/22 | 01/06/22 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2016 | 2020 | 2021 |
|---|---|---|---|
| Net Debt 1 | 0.33 | 0.04 | - |
| Net Cash position 1 | - | - | 0.75 |
| Leverage (Debt/EBITDA) | -3.826 x | -0.0689 x | - |
| Free Cash Flow 1 | 0.07 | - | -0.05 |
| ROE (net income / shareholders' equity) | 92.9% | - | -50.2% |
| ROA (Net income/ Total Assets) | -223% | - | -28% |
| Assets 1 | 0.184 | - | 1.211 |
| Book Value Per Share 2 | -0.1800 | 0.0200 | 0.0800 |
| Cash Flow per Share 2 | 0.0100 | 0.0100 | 0.0500 |
| Capex | - | - | - |
| Capex / Sales | - | - | - |
| Announcement Date | 29/03/17 | 01/06/22 | 01/06/22 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +25.36% | 5.99M | |
| +16.86% | 8.43B | |
| +3.57% | 7.49B | |
| +4.89% | 6.23B | |
| -5.23% | 3.75B | |
| -6.58% | 3.75B | |
| -3.55% | 1.33B | |
| -28.64% | 1.09B | |
| +18.12% | 1.02B | |
| -8.60% | 933M |
- Stock Market
- Equities
- GLUC Stock
- Financials Glucose Health, Inc.
